PEAK6 Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$11.2M Buy
+101,600
New +$10.6M 0.05% 404
2018
Q1
Sell
-1,900
Closed -$187K 4438
2017
Q4
$187K Sell
1,900
-21,100
-92% -$2M ﹤0.01% 3202
2017
Q3
$2.15M Buy
23,000
+10,400
+83% +$1.1M 0.01% 1328
2017
Q2
$1.4M Buy
12,600
+12,400
+6,200% +$1.31M 0.01% 1639
2017
Q1
$20K Sell
200
-71,500
-100% -$6.82M ﹤0.01% 4058
2016
Q4
$6.59M Sell
71,700
-17,200
-19% -$1.48M 0.05% 551
2016
Q3
$7.52M Sell
88,900
-82,800
-48% -$6.95M 0.06% 482
2016
Q2
$14M Buy
171,700
+90,200
+111% +$6.87M 0.11% 202
2016
Q1
$5.82M Sell
81,500
-184,300
-69% -$12.4M 0.05% 532
2015
Q4
$18.9M Buy
265,800
+178,000
+203% +$12M 0.13% 166
2015
Q3
$5.4M Buy
87,800
+16,400
+23% +$1.15M 0.03% 832
2015
Q2
$5.18M Buy
71,400
+46,900
+191% +$3.46M 0.03% 809
2015
Q1
$1.88M Buy
24,500
+22,000
+880% +$1.58M 0.01% 1338
2014
Q4
$168K Buy
+2,500
New +$158K ﹤0.01% 3497
2014
Q3
Sell
-24,800
Closed -$1.46M 4746
2014
Q2
$1.46M Sell
24,800
-16,400
-40% -$960K 0.01% 1327
2014
Q1
$2.39M Buy
41,200
+28,100
+215% +$1.51M 0.02% 1135
2013
Q4
$701K Sell
13,100
-39,100
-75% -$2.32M ﹤0.01% 2365
2013
Q3
$1.61M Buy
52,200
+24,200
+86% +$1.45M 0.01% 1721
2013
Q2
$1.7K Buy
+28,000
New +$1.67M 0.01% 1678

Other funds holding DGX

PEAK6 Group's DGX Position: Q1 2018 in Review

PEAK6 Group sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 12,392 shares — an estimated $1.22M sold.

PEAK6 Group first reported a position in DGX in Q2 2013 and held it in 9 quarters. The position peaked at $1.22M in Q4 2017. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • PEAK6 Group reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 12,392 Quest Diagnostics shares in Q1 2018, an estimated $1.22M.
  • PEAK6 Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 9 quarters.
  • PEAK6 Group's Quest Diagnostics position peaked at $1.22M in Q4 2017.
  • 652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.